Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — Share Price, Financials & Ratios

Key Fundamentals

LargecapHospitalsHealthcare Services

Market Cap

1.2L Cr

Volatility

Moderate

P/E Ratio

63.63

EBITDA

₹3,750 Cr

Return on Equity

12.53%

Debt to Equity

0.61

Book Value

₹658.78

EPS

₹72.05

52W High

₹8,624

52W Low

₹6,696.5

Technical Indicators

Key Insights

Strengths

2

Company has delivered good profit growth of 77.8% CAGR over last 5 years
Company has been maintaining a healthy dividend payout of 17.7%

Weaknesses

2

Stock is trading at 13.0 times its book value
Company might be capitalizing the interest cost

Growth Rate

Revenue Growth

14.70% ↗

Net Income Growth

34.98% ↗

Cash Flow Change

11.26% ↗

ROE

36.18% ↗

ROCE

2.58% ↘

EBITDA Margin (Avg.)

0.55% ↘

AI Analysis — Bull vs Bear

anthropic

claude-opus-4.6 1d ago

BUY

Risk medium

Apollo Hospitals trades at a premium PE of 60.8x, but delivers exceptional profit growth of 78% CAGR over 5 years and consistent 21% stock CAGR over 10 years. With 84.6% analyst buy ratings and improving ROE of 22%, the structural healthcare growth story justifies a buy with a long-term horizon.

Bull Case 8

Exceptional profit growth of 78% CAGR over 5 years, far outpacing the healthcare sector average
Consistent stock price CAGR of 21% across 1-year, 5-year, and 10-year periods demonstrates sustained wealth creation
Overwhelming analyst consensus with 84.62% buy ratings (22 out of 26 analysts recommend buy)
ROE has improved from 13% (10-year average) to 22% last year, indicating strengthening capital efficiency
TTM profit growth of 40% shows continued earnings momentum even on a higher base
Revenue CAGR of 15-19% across multiple timeframes demonstrates durable topline growth
Market cap of Rs 1,22,871 crore provides institutional-grade liquidity and index inclusion benefits
Healthy dividend payout ratio of 17.7% signals management confidence in sustainable cash flows

Bear Case 7

PE ratio of 60.8x is extremely expensive, leaving minimal margin of safety for execution misses
Price-to-book of 12.86x suggests stock is pricing in years of future growth already
Dividend yield of just 0.12% offers negligible income return for investors
Potential capitalization of interest costs may be inflating reported profits and asset values
Only 3.85% sell rating (1 analyst) suggests potential crowded consensus trade with limited contrarian scrutiny
TTM sales growth of 16% is decelerating from 5-year CAGR of 19%, hinting at maturing growth curve
At 60.8x PE, even a modest earnings miss could trigger 20-30% valuation de-rating given premium multiple

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

anthropic

claude-opus-4.6 1d ago

Neutral 3

Healthtech governance framework detailed Jun 19

Apollo Hospitals disclosed director nomination rights tied to shareholding thresholds (10% aggregate, 5% individual) for the proposed Apollo Healthtech listing, with half the board to be independent directors and Ms. Shobana Kamineni proposed as Executive Chairperson.
Senior oncology executive resigns May 30

President of Group Oncology and International, Mr. Dinesh Madhavan, resigned effective May 30, 2026, potentially leaving a leadership gap in the oncology and international business verticals.
₹28.46 Cr institutional block trade May 26

Approximately 34,036 shares were traded at ₹8,361.50 per share in a privately negotiated block deal on NSE valued at ₹28.46 crores, indicating routine institutional activity with minimal market impact.

TL;DR: Recent news flow for Apollo Hospitals is procedural and governance-oriented with no material positive catalysts or significant risks emerging. The Healthtech listing preparations are progressing through regulatory steps, while a senior executive departure bears watching for continuity in the oncology segment. Overall, the near-term narrative is steady-state with no clear directional signal from these developments.

Quarterly Results

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	4,302	4,418	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304	6,477	6,606
Expenses	3,814	3,909	4,219	4,237	4,303	4,410	4,774	4,765	4,822	4,990	5,362	5,512	5,594
Operating Profit	488	509	628	614	640	675	816	762	770	852	941	965	1,011
OPM %	11%	12%	13%	13%	13%	13%	15%	14%	14%	15%	15%	15%	15%
Other Income	20	34	26	29	37	49	44	69	72	54	61	48	54
Interest	95	106	111	113	119	116	118	110	115	108	110	113	119
Depreciation	159	167	163	167	190	177	184	185	211	215	218	219	224
PBT	254	270	379	363	368	430	557	536	516	583	675	682	722
Tax %	43%	36%	34%	30%	30%	27%	29%	29%	20%	24%	27%	24%	24%
Net Profit	146	173	249	254	258	316	396	379	414	441	494	516	551
EPS in Rs	10.05	11.59	16.2	17.06	17.65	21.23	26.34	25.89	27.1	30.1	33.19	34.93	36.81

Show % Change

Figures in ₹ Crores

Profit & Loss

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	5,129	6,150	7,256	8,243	9,617	11,247	10,560	14,663	16,612	19,059	21,794	25,228
Expenses	4,392	5,465	6,522	7,442	8,548	9,656	9,420	12,474	14,548	16,665	18,761	21,459
Operating Profit	737	684	734	801	1,070	1,591	1,140	2,189	2,065	2,394	3,033	3,769
OPM %	14%	11%	10%	10%	11%	14%	11%	15%	12%	13%	14%	15%
Other Income	47	92	60	24	26	222	103	368	75	123	222	217
Interest	118	180	257	295	327	533	449	379	381	449	458	450
Depreciation	212	264	314	359	396	620	573	601	615	687	758	876
PBT	455	332	222	171	373	660	221	1,578	1,144	1,380	2,039	2,661
Tax %	29%	29%	41%	65%	47%	34%	38%	30%	22%	32%	26%	25%
Net Profit	335	235	131	60	200	432	137	1,108	844	935	1,505	2,003
EPS in Rs	24.43	16.99	15.88	8.44	16.96	32.7	10.46	73.42	56.97	62.5	101	135
Div. Payout %	24%	35%	38%	59%	35%	18%	29%	16%	26%	26%	13%	15%

Show % Change

Figures in ₹ Crores

Balance Sheet

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	70	70	70	70	70	70	72	72	72	72	72	72
Reserves	3,102	3,262	3,244	3,182	3,264	3,270	4,531	5,551	6,126	6,864	8,140	9,408
Borrowings	1,992	2,834	3,125	3,427	3,673	3,596	4,160	4,068	4,332	5,333	7,864	8,493
Other Liabilities	1,296	1,195	1,665	1,917	2,159	4,354	2,629	3,570	3,886	4,474	4,568	4,224
Total Liabilities	6,459	7,360	8,103	8,596	9,166	11,289	11,392	13,261	14,416	16,742	20,644	22,197
Fixed Assets	3,244	3,997	4,591	4,773	4,982	7,432	6,778	8,296	8,520	9,664	10,988	12,312
CWIP	533	562	347	712	822	236	234	46	610	873	921	992
Investments	311	352	406	352	462	434	1,343	816	574	986	2,487	2,179
Other Assets	2,372	2,448	2,759	2,759	2,901	3,187	3,037	4,104	4,712	5,219	6,248	6,714
Total Assets	6,459	7,360	8,103	8,596	9,166	11,289	11,392	13,261	14,416	16,742	20,644	22,197

Show % Change

Figures in ₹ Crores

Cash Flow

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating	470	597	623	537	905	1,293	1,265	1,696	1,377	1,920	2,136	2,856
Investing	-759	-888	-1,152	-405	-711	-289	-880	-747	-857	-1,537	-3,381	-2,148
Financing	392	330	477	-108	-215	-910	-340	-792	-633	-311	1,317	-478
Net Cash Flow	103	39	-52	24	-20	94	44	158	-113	72	73	230
Free Cash Flow	-396	-393	-46	-84	233	782	984	1,044	252	785	439	925
CFO/OP	77	108	103	83	103	100	108	87	85	100	86	92

Show % Change

Figures in ₹ Crores

Ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	43	36	38	37	39	33	46	44	49	48	51	50
Inventory Days	50	49	47	51	46	49	16	21	17	17	16	15
Days Payable	59	66	51	55	56	60	74	79	82	88	72	63
Cash Conversion Cycle	34	19	34	33	29	22	-12	-14	-16	-23	-6	3
Working Capital Days	24	16	27	8	-3	-8	-4	5	-1	-19	-6	-10
ROCE %	12%	9%	8%	7%	10%	14%	8%	17%	14%	15%	17%	18%

Show % Change

Shareholding Pattern

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	29.82%	29.82%	29.82%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.34%	29.34%	28.02%	28.02%	28.02%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	45.63%	43.92%	45.37%	45.27%	42.74%	43.49%	44.20%	43.54%	42.62%
DIIs	9.16%	10.84%	12.24%	12.13%	12.45%	14.89%	14.59%	16.56%	17.76%	16.31%	18.60%	17.97%	19.55%	21.14%	19.95%	19.98%	22.29%	21.34%	21.12%	21.51%	22.76%
Government	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%
Public	4.07%	3.99%	4.24%	4.03%	4.27%	4.48%	4.23%	4.13%	4.04%	3.90%	4.04%	3.70%	3.74%	3.81%	3.62%	3.65%	3.81%	3.98%	4.44%	4.70%	4.39%
Others	56.73%	55.13%	53.47%	54.29%	53.73%	51.07%	51.63%	49.75%	48.64%	50.23%	47.80%	48.76%	1.52%	1.57%	1.50%	1.54%	1.60%	1.62%	1.99%	2.01%	1.98%
No. of Shareholders	67,091	75,153	98,452	99,135	1,26,226	1,46,320	1,35,923	1,31,636	1,31,937	1,20,030	1,31,565	1,19,578	1,30,664	1,27,754	1,19,245	1,27,802	1,34,058	1,41,007	1,60,556	1,78,648	1,74,610

Show % Change

Documents

1

Concall - Jun 2021 Jun 2021

PPT

2

Concall - May 2026 May 2026

PPT Recording

3

Concall - May 2026 May 2026

PPT

4

Concall - Nov 2015 Nov 2015

PPT

5

Concall - Feb 2016 Feb 2016

Transcript

Frequently Asked Questions about Apollo Hospitals Enterprise Ltd

What does Apollo Hospitals Enterprise Ltd do?

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremo...

Where is Apollo Hospitals Enterprise Ltd (APOLLOHOSP) listed?

Apollo Hospitals Enterprise Ltd is listed on the Indian stock exchanges. It is listed on NSE: APOLLOHOSP and BSE: 508869. You can view its live share price, financials, and ratios on Tapetide.

Which sector does Apollo Hospitals Enterprise Ltd belong to?

Apollo Hospitals Enterprise Ltd operates in the Healthcare sector within the Healthcare Services industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.

What is the market capitalisation of Apollo Hospitals Enterprise Ltd?

Apollo Hospitals Enterprise Ltd has a market capitalisation of approximately ₹122863.99 Cr. Based on this, it is classified as a Large Cap stock.

What is the PE ratio of Apollo Hospitals Enterprise Ltd?

The Price-to-Earnings (PE) ratio of Apollo Hospitals Enterprise Ltd is 63.63. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.

What is the 52-week high and low of Apollo Hospitals Enterprise Ltd?

Over the past 52 weeks, Apollo Hospitals Enterprise Ltd has traded between a low of ₹6,696.5 and a high of ₹8,624. This range helps investors understand the stock's price volatility and recent trading levels.

Does Apollo Hospitals Enterprise Ltd pay dividends?

Yes, Apollo Hospitals Enterprise Ltd has a dividend yield of 0.12%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.

What is the Return on Equity (ROE) of Apollo Hospitals Enterprise Ltd?

Apollo Hospitals Enterprise Ltd has a Return on Equity (ROE) of 12.53%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.

How can I research Apollo Hospitals Enterprise Ltd on Tapetide?

On Tapetide, you can view Apollo Hospitals Enterprise Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.